Abstract
In the past two decades, a substantial increase in the incidence of acute kidney injury (AKI) and kidney injury requiring dialysis has occurred in North America. This increase has coincided with an increase in the incidence of end-stage renal disease (ESRD), which has exceeded that expected based upon the prevalence of chronic kidney disease (CKD). In order to better understand the association between these conditions, there has been a proliferation of studies that have examined the risks of incident and progressive CKD following AKI. Animal studies have shown that failed differentiation of epithelial cells following renal ischaemia–reperfusion injury might lead to tubulointerstitial fibrosis, supporting a biological mechanism linking AKI and CKD. Strong and consistent associations between AKI and incident CKD, progression of CKD and incident ESRD have also been shown in epidemiological studies. In this Review, we summarize the wealth of available data on the relationship between AKI and CKD, and discuss the implications of these findings for the long-term clinical management of patients following AKI. We also identify areas of active investigation and future directions for research.
Key Points
-
The increase in incidence of acute kidney injury (AKI) in the past two decades has coincided with an increase in the incidence of end-stage renal disease (ESRD)
-
Epidemiological studies have consistently shown that AKI is a risk factor for incident chronic kidney disease (CKD), progression of CKD and incident ESRD
-
The 2012 KDIGO AKI guidelines recommend that patients should be evaluated 3 months after an episode of AKI to assess recovery, development of incident CKD or worsening of pre-existing CKD
-
The development of new tools to identify patients at high risk of progressive CKD after AKI is required
-
Further research into interventions that could potentially slow the progression of kidney disease and improve long-term patient outcomes after AKI is required
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Levey, A. S. et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann. Intern. Med. 139, 137–147 (2003).
Taal, M. W. et al. Brenner & Rector's: The Kidney 9th edn. Ch. 19. Epidemiology of kidney disease. 728–739 (Elsevier Saunders, Philadelphia, 2012).
Hemmelgarn, B. R. et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA 303, 423–429 (2010).
Whaley-Connell, A. T. et al. CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999–2004. Am. J. Kidney Dis. 51 (Suppl. 2), S13–S20 (2008).
Coresh, J. et al. Prevalence of chronic kidney disease in the United States. JAMA 298, 2038–2047 (2007).
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. & Hsu, C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296–1305 (2004).
Keith, D. S., Nichols, G. A., Gullion, C. M., Brown, J. B. & Smith, D. H. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch. Intern. Med. 164, 659–663 (2004).
United States Renal Data System. 2009 USRDS Annual Data Report: Atlas of End-Stage Renal Disease in the United States. United States Renal Data System [online], (2009).
United States Renal Data System. 2011 USRDS Annual Data Report: atlas of end-stage renal disease in the United States. United States Renal Data System [online], (2011).
Eknoyan, G. et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N. Engl. J. Med. 347, 2010–2019 (2002).
Paniagua, R. et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J. Am. Soc. Nephrol. 13, 1307–1320 (2002).
Pagels, A. A., Söderkvist, B. K., Medin, C., Hylander, B. & Heiwe, S. Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment. Health Qual. Life Outcomes 10, 71 (2012).
Bellomo, R. et al. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care 8, R204–R212 (2004).
Bagshaw, S. M., George, C. & Bellomo, R. A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol. Dial. Transplant. 23, 1569–1574 (2008).
Mehta, R. L. et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit. Care 11, R31 (2007).
Nash, K., Hafeez, A. & Hou, S. Hospital-acquired renal insufficiency. Am. J. Kidney Dis. 39, 930–936 (2002).
Hou, S. H., Bushinsky, D. A., Wish, J. B., Cohen, J. J. & Harrington, J. T. Hospital-acquired renal insufficiency: a prospective study. Am. J. Med. 74, 243–248 (1983).
Hsu, C. Y. et al. Community-based incidence of acute renal failure. Kidney Int. 72, 208–212 (2007).
Hsu, C. Y. Where is the epidemic in kidney disease? J. Am. Soc. Nephrol. 21, 1607–1611 (2010).
Coca, S. G., Yusuf, B., Shlipak, M. G., Garg, A. X. & Parikh, C. R. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am. J. Kidney Dis. 53, 961–973 (2009).
Hsu, C. Y., Vittinghoff, E., Lin, F. & Shlipak, M. G. The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann. Intern. Med. 141, 95–101 (2004).
Ishani, A. et al. Acute kidney injury increases risk of ESRD among elderly. J. Am. Soc. Nephrol. 20, 223–228 (2009).
Coca, S. G., Singanamala, S. & Parikh, C. R. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 81, 442–448 (2012).
Levin, A., Kellum, J. A. & Mehta, R. L. Acute kidney injury: toward an integrated understanding through development of a research agenda. Clin. J. Am. Soc. Nephrol. 3, 862–863 (2008).
Waikar, S. S. et al. Validity of international classification of diseases, ninth revision, clinical modification codes for acute renal failure. J. Am. Soc. Nephrol. 17, 1688–1694 (2006).
James, M. & Pannu, N. Methodological considerations for observational studies of acute kidney injury using existing data sources. J. Nephrol. 22, 295–305 (2009).
Rifkin, D. E., Coca, S. G. & Kalantar-Zadeh, K. Does AKI truly lead to CKD? J. Am. Soc. Nephrol. 23, 979–984 (2012).
Lerma, E., Berns, J. S. & Nissenson, A. Current diagnosis & treatment: nephrology & hypertension. 89–99 (McGraw-Hill Companies, Inc., USA 2009).
Palevsky, P. M. et al. Intensity of renal support in critically ill patients with acute kidney injury. N. Engl. J. Med. 359, 7–20, (2008).
Bellomo, R. et al. Intensity of continuous renal-replacement therapy in critically ill patients. N. Engl. J. Med. 361, 1627–1638 (2009).
Palmer, R. A. & Henry, E. W. The clinical course of acute renal failure; observations on 54 cases. Can. Med. Assoc. J. 77, 1078–1084 (1957).
Swann, R. C. & Merrill, J. P. The clinical course of acute renal failure. Medicine (Baltimore) 32, 215–292 (1953).
Basile, D. P., Donohoe, D., Roethe, K. & Osborn, J. L. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am. J. Physiol. Renal Physiol. 281, F887–F899 (2001).
Spurgeon-Pechman, K. R. et al. Recovery from acute renal failure predisposes hypertension and secondary renal disease in response to elevated sodium. Am. J. Physiol. Renal Physiol. 293, F269–F278 (2007).
Basile, D. P., Leonard, E. C., Beal, A. G., Schleuter, D. & Friedrich, J. Persistent oxidative stress following renal ischemia–reperfusion injury increases ang II hemodynamic and fibrotic activity. Am. J. Physiol. Renal Physiol. 302, F1494–F1502 (2012).
Geng, H. et al. Inhibition of autoregulated TGFβ signaling simultaneously enhances proliferation and differentiation of kidney epithelium and promotes repair following renal ischemia. Am. J. Pathol. 174, 1291–1308 (2009).
Menke, J. et al. CSF-1 signals directly to renal tubular epithelial cells to mediate repair in mice. J. Clin. Invest. 119, 2330–2342 (2009).
Spurgeon, K. R., Donohoe, D. L. & Basile, D. P. Transforming growth factor-β in acute renal failure: receptor expression, effects on proliferation, cellularity, and vascularization after recovery from injury. Am. J. Physiol. Renal Physiol. 288, F568–F577 (2005).
Terzi, F. et al. Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury. J. Clin. Invest. 106, 225–234 (2000).
Zeng, F., Singh, A. B. & Harris, R. C. The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology. Exp. Cell Res. 315, 602–610 (2009).
Park, K. M., Chen, A. & Bonventre, J. V. Prevention of kidney ischemia/reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J. Biol. Chem. 276, 11870–11876 (2001).
Jang, H. R. & Rabb, H. The innate immune response in ischemic acute kidney injury. Clin. Immunol. 130, 41–50 (2009).
Bonventre, J. V. & Weinberg, J. M. Recent advances in the pathophysiology of ischemic acute renal failure. J. Am. Soc. Nephrol. 14, 2199–2210 (2003).
Ramesh, G. & Reeves, W. B. TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J. Clin. Invest. 110, 835–842 (2002).
Safirstein, R. L. Acute renal failure: from renal physiology to the renal transcriptome. Kidney Int. Suppl. 91, S62–S66 (2004).
Suzuki, T., Kimura, M., Asano, M., Fujigaki, Y. & Hishida, A. Role of atrophic tubules in development of interstitial fibrosis in microembolism-induced renal failure in rat. Am. J. Pathol. 158, 75–85 (2001).
Wallin, A., Zhang, G., Jones, T. W., Jaken, S. & Stevens, J. L. Mechanism of the nephrogenic repair response. Studies on proliferation and vimentin expression after 35S-1,2-dichlorovinyl-L-cysteine nephrotoxicity in vivo and in cultured proximal tubule epithelial cells. Lab. Invest. 66, 474–484 (1992).
Ward, J. M. et al. Vimentin metaplasia in renal cortical tubules of preneoplastic, neoplastic, aging, and regenerative lesions of rats and humans. Am. J. Pathol. 141, 955–964 (1992).
Venkatachalam, M. A. et al. Acute kidney injury: a springboard for progression in chronic kidney disease. Am. J. Physiol. Renal Physiol. 298, F1078–F1094 (2010).
Basile, D. P., Fredrich, K., Chelladurai, B., Leonard, E. C. & Parrish, A. R. Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor. Am. J. Physiol. Renal Physiol. 294, F928–F936 (2008).
Basile, D. P. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int. 72, 151–156 (2007).
Hsu, C. Y. et al. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int. 74, 101–107 (2008).
Bartholomew, B. A. et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am. J. Cardiol. 93, 1515–1519 (2004).
James, M. T. et al. Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet 376, 2096–2103 (2010).
Hsu, R. K. & Hsu, C. Y. Proteinuria and reduced glomerular filtration rate as risk factors for acute kidney injury. Curr. Opin. Nephrol. Hypertens. 20, 211–217 (2011).
Wald, R. et al. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 302, 1179–1185 (2009).
Amdur, R. L., Chawla, L. S., Amodeo, S., Kimmel, P. L. & Palant, C. E. Outcomes following diagnosis of acute renal failure in US veterans: focus on acute tubular necrosis. Kidney Int. 76, 1089–1097 (2009).
Ishani, A. et al. The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch. Intern. Med. 171, 226–233 (2011).
Garg, A. X. et al. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA 290, 1360–1370 (2003).
Askenazi, D. J., Feig, D. I., Graham, N. M., Hui-Stickle, S. & Goldstein, S. L. 3–5 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int. 69, 184–189 (2006).
Mammen, C. et al. Long-term risk of CKD in children surviving episodes of acute kidney injury in the intensive care unit: a prospective cohort study. Am. J. Kidney Dis. 59, 523–530 (2012).
Lo, L. J. et al. Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int. 76, 893–899 (2009).
James, M. T. et al. Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function. Kidney Int. 78, 803–809 (2010).
Go, A. S. et al. The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol. 11, 22 (2010).
Hsu, C. Y. Yes, AKI truly leads to CKD. J. Am. Soc. Nephrol. 23, 967–969 (2012).
Siew, E. D. et al. Outpatient nephrology referral rates after acute kidney injury. J. Am. Soc. Nephrol. 23, 305–312 (2012).
Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. Suppl. 2, 1–138 (2012).
Chawla, L. S., Amdur, R. L., Amodeo, S., Kimmel, P. L. & Palant, C. E. The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int. 79, 1361–1369 (2011).
Bucaloiu, I. D., Kirchner, H. L., Norfolk, E. R., Hartle, J. E. 2nd & Perkins, R. M. Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int. 81, 477–485 (2012).
Koyner, J. L. et al. Biomarkers predict progression of acute kidney injury after cardiac surgery. J. Am. Soc. Nephrol. 23, 905–914 (2012).
Clerico, A., Galli, C., Fortunato, A. & Ronco, C. Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences. Clin. Chem. Lab. Med. 50, 1505–1517 (2012).
Adiyanti, S. S. & Loho, T. Acute kidney injury (AKI) biomarker. Acta Med. Indones. 44, 246–255 (2012).
Zappitelli, M. et al. The association of albumin/creatinine ratio with postoperative AKI in children undergoing cardiac surgery. Clin. J. Am. Soc. Nephrol. 7, 1761–1769 (2012).
Spahillari, A. et al. Serum cystatin C- versus creatinine-based definitions of acute kidney injury following cardiac surgery: a prospective cohort study. Am. J. Kidney Dis. 60, 922–929 (2012).
Parikh, C. R. et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J. Am. Soc. Nephrol. 22, 1737–1747 (2011).
Parikh, C. R. et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J. Am. Soc. Nephrol. 22, 1748–1757 (2011).
Shlipak, M. G. et al. Presurgical serum cystatin C and risk of acute kidney injury after cardiac surgery. Am. J. Kidney Dis. 58, 366–373 (2011).
Li, S. et al. Incidence, risk factors, and outcomes of acute kidney injury after pediatric cardiac surgery: a prospective multicenter study. Crit. Care Med. 39, 1493–1499 (2011).
Zappitelli, M. et al. Early postoperative serum cystatin C predicts severe acute kidney injury following pediatric cardiac surgery. Kidney Int. 80, 655–662 (2011).
Author information
Authors and Affiliations
Contributions
K. C. W. Leung and M. T. James researched the data for the article, provided substantial contribution to discussions of the content, wrote the article and reviewed and/or edited the manuscript before submission. M. Tonelli provided substantial contributions to discussions of the content and reviewed and/or edited the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Table 1
Studies that have examined the association between AKI and the subsequent risk of CKD or ESRD (DOC 63 kb)
Rights and permissions
About this article
Cite this article
Leung, K., Tonelli, M. & James, M. Chronic kidney disease following acute kidney injury—risk and outcomes. Nat Rev Nephrol 9, 77–85 (2013). https://doi.org/10.1038/nrneph.2012.280
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2012.280
This article is cited by
-
The effects of apoptosis inhibitor of macrophage in kidney diseases
European Journal of Medical Research (2024)
-
Dietary inflammatory index is associated with Vitamin D in CKD patients
International Urology and Nephrology (2023)
-
An acute phase protein α1-acid glycoprotein mitigates AKI and its progression to CKD through its anti-inflammatory action
Scientific Reports (2021)
-
NLRP3 associated with chronic kidney disease progression after ischemia/reperfusion-induced acute kidney injury
Cell Death Discovery (2021)
-
Kidney disease in children with heart or liver transplant
Pediatric Nephrology (2021)